ST. LOUIS, June 17 /PRNewswire-FirstCall/ -- Allied Healthcare Products, Inc. today announced introduction of Litholyme(TM), a new premium carbon dioxide absorbent that provides enhanced patient safety over conventional absorbents in anesthesia procedures.
"Litholyme features a patented formulation that eliminates the safety issues commonly associated with conventional carbon dioxide absorbents, yet it has been developed in such a manner that it can be offered at a similar price to conventional or non-premium absorbents," said Jack Dabrowski, senior product manager.
"Other premium carbon dioxide absorbents that exist in the market today also provide increased safety but are much more costly than conventional absorbents, limiting their adoption in hospitals. We expect that Litholyme's balance of performance, safety and cost will broaden the use of this safer formulation," Dabrowski said.
Allied Healthcare Products, Inc., manufactures a variety of respiratory products used in the healthcare industry in a range of hospital and alternate care settings including sub-acute facilities, home healthcare and emergency medical care. Allied product lines include respiratory care products, medical gas equipment and emergency medical products. Allied products are marketed to hospitals, hospital equipment dealers, hospital construction contractors, home healthcare dealers and emergency medical products dealers.
"SAFE HARBOR" STATEMENT: Statements contained in this release that are not historical facts or information are "forward-looking statements." Words such as "believe," "expect," "intend," "will," "should," and other expressions that indicate future events and trends identify such forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome and future results of operations and financial condition to be materially different than stated or anticipated based on the forward-looking statements. Such risks and uncertainties include both general economic risks and uncertainties, risks and uncertainties affecting the demand for and economic factors affecting the delivery of health care services, and specific matters which relate directly to the Company's operations and properties as discussed in its periodic filings with the Securities and Exchange Commission. The Company cautions that any forward-looking statement contained in this report reflects only the belief of the Company or its management at the time the statement was made. Although the Company believes such forward-looking statements are based upon reasonable assumptions, such assumptions may ultimately prove inaccurate or incomplete. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement was made.
Allied Healthcare Products, Inc.
CONTACT: Daniel C. Dunn, Chief Financial Officer of Allied Healthcare
Products, Inc., +1-314-771-2400
Web Site: http://www.alliedhpi.com/
